Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28 GBX | -6.67% | -9.68% | -39.13% |
05/04 | Transcript : LungLife AI, Inc., 2023 Earnings Call, Apr 05, 2024 | |
04/04 | LungLife reports narrowed losses in year of "considerable achievement" | AN |
Sales 2023 | 46K 3.84M | Sales 2024 * | 100K 8.34M | Capitalization | 10.69M 892M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | -3 -250.13 | EV / Sales 2023 | 324 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | 0.6 50.03 | EV / Sales 2024 * | 107 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-2.64
x | Employees | 15 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 51.29% |
Latest transcript on LungLife AI, Inc.
1 day | -6.67% | ||
1 week | -9.68% | ||
Current month | -6.67% | ||
1 month | -9.68% | ||
3 months | -32.53% | ||
6 months | -68.89% | ||
Current year | -39.13% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Pagano
CEO | Chief Executive Officer | 40 | - |
David Anderson
DFI | Director of Finance/CFO | 61 | - |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gordon Davis
CHM | Chairman | 67 | 08/21/08 |
Andrew Boteler
BRD | Director/Board Member | 58 | 08/21/08 |
David Anderson
DFI | Director of Finance/CFO | 61 | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 28 | -6.67% | 10,000 |
25/24/25 | 30 | -3.23% | 50,180 |
24/24/24 | 31 | 0.00% | 3,682 |
23/24/23 | 31 | 0.00% | 319 |
22/24/22 | 31 | 0.00% | 100 |
Delayed Quote London S.E., April 26, 2024 at 09:05 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.13% | 10.69M | |
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-17.21% | 2.08B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-37.00% | 391M | |
-46.94% | 383M |
- Stock Market
- Equities
- LLAI Stock